What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its ability to stimulate pulsatile growth hormone secretion. Randomized controlled trials have documented significant reductions in visceral adipose tissue, making it one of the most clinically characterized GHRH analogs in published research.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) stabilized with a trans-3-hexenoic acid modification that protects it from enzymatic degradation and extends its biological half-life. It binds GHRH receptors in the anterior pituitary, stimulating the release of endogenous growth hormone in a pulsatile, physiological pattern. Randomized controlled trials — most prominently in HIV-associated lipodystrophy — documented statistically significant reductions in visceral adipose tissue over 26–52 weeks. Because of this clinical record, tesamorelin serves as a well-characterized reference compound in GHRH-axis research.
Tesamorelin — 2mg, 98.86% purity →
More on Metabolic
Summarised from peer-reviewed literature for research reference. For laboratory research use only.